After a net decline in 2004, Sanofi-Aventis workforce are left on the rise in 2005. The employees of the French laboratory were 700 more score on December 31, bringing the total to about 97.200 people around the world. Evolution is modest at the scale of the number three global pharmacy ( 0.8), but it hides important movements.
The most spectacular is the vaccines, where membership increased from 11 in one year, with the creation of 900 positions. The sector represents only a small part of the turnover of the Group (8), but it is in strong growth ( 27 last year), the success of products against flu and meningitis. The wave of hiring has benefited the sites of Val-de-Reuil (Seine-Maritime) and Marcy - l'Etoile (Rhône).
Stable employment in the factories
Sanofi has also recruited and des à Etats-Unis, où sa force de vente est passée de 8.000 à 9.400 personnes en l' espace de douze mois in United States, where its sales force from 8,000 to 9.400 people in the space of twelve months. The French had to strengthen its teams to ensure the launch of Ambien CR, a new version of the sleeping pill Stilnox marketed since October. It has the most powerful sales force 2 e transatlantic behind Pfizer.
"In total, we have employed 12,000 people in 2005", welcomed Frédéric Cluzel, Director of the social relations of the laboratory. The Group also hired in its Department of research and development, where the workforce rose by 3. R & D employs 17.600 people for an annual budget of EUR 4 billion. The recruitments were also important in China, where the demand for drugs is growing strong and India.
In factories, employing 31,000 people, employment remained stable ( 1). "For industrial sites, the Group appealed much to temporary workers and CSD, is observed a CGT representative.". In some French factories, the precarious employment rate reached 20.
These hirings helped to offset reductions in workforce among the medical visitors in France, the number rose from 4,000 to smics people. It is the result of the merger of commercial teams of Sanofi and Aventis. No dismissal was necessary. "Deletions of posts were made by early, on the basis of voluntary retirement," says the CGT representative. This departure plan draws to a close, but unions fear the new wave in 2006. "The beginning of the year is very bad in France", is concerned about Daniel Thébault, CFE - CGC Union steward. Sanofi is affected, as all the laboratories, by the savings measures for insurance taken by the Government. "It can if wait a new restructuring in 2006," it concerned.
Calm social climate
The Group has also deleted posts administrative functions (computer science, accounting, management...) by consolidating the headquarters of Sanofi and Aventis in all countries. These functions of "support" were reduced by 13 to 13.600 people in one year.
A thousand posts is also out of the perimeter of the enterprise through assignments such as activities for maintenance in Germany and two industrial sites in the United States and Slovakia. In spite of these various reorganizations, the social climate remained calm since the merger. "There was no strikes or social movements of magnitude", welcomes Daniel Thébault.
We had enough to ensure the flight programIt advances two arguments to convince themThe dédiabolisation plays but not in fullIt is important that workers are aware of the facts5 billion it could be launched in 2011 or 2012Camilla is a lovely Swedish of middle ageHow easiest to do this is through a bank he added The Federal selection balance profile gave 6Target Martine Aubry was not based on nothingIt exercises this jurisdiction with professionalism
